The prevalence of these genetic alterations sums up to more than 50% of the patients of the mesothelioma cohort (MESO) of The Cancer Genome Atlas (TCGA; US National Cancer Institute, https://www.cancer.gov) and suggests a role for YAP1 activity in MPM tumor growth. Here, YAP1 is linked to mesothelioma.